Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY   US1101221083

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Bristol Myers Squibb : Assigned Patent

07/25/2014 | 07:18am US/Eastern

By Targeted News Service

ALEXANDRIA, Va., July 25 -- Bristol-Myers Squibb, Princeton, New Jersey, has been assigned a patent (8,785,398) developed by four co-inventors for the "methods of treatment using CTLA4 mutant molecules." The co-inventors are Robert James Peach, San Diego, Joseph Naemura, Bellevue, Washington, Peter S. Linsley, Seattle, and Jurgen Bajorath, Bonn, Germany.

The patent application was filed on Oct. 20, 2011 (13/277,425). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=87,85,398.PN.&OS=PN/87,85,398&RS=PN/87,85,398

Written by Sudarshan Harpal; edited by Jaya Anand.

SH0725JA0725-1039881

(c) 2014 Targeted News Service

React to this article
Latest news on BRISTOL-MYERS SQUIBB CO
07/02 Celldex Therapeutics Appoints Richard Wright as Chief Commercial Officer
07/01 BRISTOL MYERS SQUIBB : Trademark Application for "I'M HERE" Filed by Bristol-Mye..
07/01 BRISTOL MYERS SQUIBB : Trademark Application for "APRIL" Filed by Bristol-Myers ..
07/01 BRISTOL MYERS SQUIBB : New Findings in Obesity Described from Bristol-Myers Squi..
07/01 BRISTOL MYERS SQUIBB : Study Results from Bristol-Myers Squibb Update Understand..
07/01 BRISTOL MYERS SQUIBB : European Commission Approves Bristol-Myers Squibb's Opdiv..
07/01 BRISTOL-MYERS SQUIBB CO : ex-dividend day
06/29 BRISTOL MYERS SQUIBB : Society for Immunotherapy of Cancer Reacts to EMA Approva..
06/27 BRISTOL MYERS SQUIBB : Gets European Commission Approval for Opdivo (nivolumab)
06/26 BRISTOL MYERS SQUIBB : Alexandria Real Estate Equities, Inc. : Announces 15-Year..
Advertisement
Chart
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Income Statement Evolution
More Financials